GUANGZHOU, China, 19. Januar 2025 /PRNewswire/ -- Guangzhou Fermion Technology Co., Ltd. und Simcere Pharmaceutical Group Limited (HKEX: 2096) haben eine Partnerschaft zur Entwicklung des Schmerzmittels FZ002-037 bekannt gegeben, das auf SSTR4 abzielt und sich im klinischen Stadium...
Hence then, the article about fermion und simcere schliessen exklusive lizenz und kooperationsvereinbarung fur chinas ersten sstr4 agonisten gegen schmerzen was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Fermion und Simcere schließen exklusive Lizenz- und Kooperationsvereinbarung für Chinas ersten SSTR4-Agonisten gegen Schmerzen )
Also on site :
- Jessica Alba Debuts Phoenix Back Tattoo Symbolizing New Beginnings
- I Tried Shake Shack's Bold New BBQ Menu and It's the Perfect Ode to Summer
- ‘Treasonous’: Trump hits out at critics, warns Iran's nuke's could have destroyed Europe, Middle East